Professor Kirsten Howard
Professor Kirsten Howard is an internationally acknowledged leader in health economics. She is Co-Director of the Menzies Centre for Health Policy and Economics, and leads a health economics group with internationally recognised expertise in patient and community preference elicitation, quality of life and wellbeing measurement, and economic evaluation. With research funding as CI in excess […]
Professor Christine Jenkins
Professor Christine Jenkins (Head of the Respiratory Group at The George Institute for Global Health) is a renowned authority in the field of airways diseases ‐ in particular Asthma and Chronic Obstructive Pulmonary Disease ‐ whose contributions have spanned from fundamental studies to large NHMRC‐funded trials (230+ publications; H‐index 50). Professor Jenkins has also contributed […]
Professor Jonathan Golledge
Professor Jonathan Golledge is an NHMRC Practitioner Fellow and vascular surgeon recognised as an international leader in artery disease. During the last 15 years, he established a translational research program which has culminated in bringing multiple new drugs and management approaches to clinical trials. The largest of these, testing a repurposed drug for artery weakening, […]
Professor Helen Marshall
Professor Helen Marshall is an international leader in vaccinology and infectious disease epidemiology, with significant and sustained achievement in vaccine research and translation to practice and policy. Her work underpins changes in vaccination practise for children, adolescents, and pregnant women in Australia and internationally. Her leadership of the largest interventional herd immunity RCT globally, published […]
Professor Penny Webb
Professor Penny Webb is recognised nationally and internationally for her work and global leadership in the epidemiology of ovarian and endometrial cancer. She is on the Steering Committee of the international Ovarian Cancer Association Consortium (OCAC) and a senior member (past Chair) of the OCAC Epidemiology Working Group. She is lead author of an epidemiology […]
Professor Rebecca Guy
Professor Rebecca Guy, Leader of the Approaches to Surveillance Cross Cutting Theme at The Kirby Institute, UNSW Sydney, is a renowned international authority in the surveillance and evaluation of public health interventions related to HIV and sexually transmissible infections. Professor Guy’s has received continuous funding by the NHMRC over the past 10 years. She has […]
Professor Tien Wong
Professor Tien Wong is a physician-scientist in ophthalmology and epidemiology who has made substantial contributions in the understanding of the global epidemiology and risk factors of visual impairment and major eye diseases, particularly diabetic retinopathy, age-related macular degeneration and myopia, three leading causes of blindness globally. For over 20 years, Professor Wong’s seminal research on […]
Professor Ingrid Winship
Professor Ingrid Winship AO FAHMS, clinician scientist in clinical genetics, cancer genetics and genodermatology, is a leader in genetics research and health services. She is Chair of the Australian Health Ethics Committee and a member of the NHMRC Council. Professor Winship has translated research in genetics and cancer prevention into state-of-the-art clinical services, alongside person […]
Professor Jerry Adams
Molecular biologist Jerry Adams has made fundamental discoveries about the molecular causes of cancer. With Suzanne Cory, he showed that the chromosome translocations hallmarking Burkitt lymphomas activate the oncogene MYC by linkage to an immunoglobulin locus enhancer and developed transgenic mice to establish causality. In 1988, David Vaux, Cory and Adams reported the seminal finding […]
Professor Suzanne Cory
Professor Suzanne Cory has made signal contributions to cancer genetics. With Jerry Adams, she showed that chromosome translocations associated with Burkitt’s lymphomas activate the oncogene MYC and proved its oncogenic role using transgenic mice. In 1988, David Vaux, Cory and Adams reported that BCL-2, the putative oncogene translocated in follicular lymphoma, acts by impairing apoptosis. […]
Professor Naomi Wray
Professor Naomi Wray is a leading complex trait geneticist. She has developed quantitative genetic methods based upon DNA marker data to understand complex genetic diseases in human populations and to predict genetic risk. In applied research, her primary focus is disorders of the brain. Professor Wray is recognised internationally for her leadership in the Psychiatric […]
Professor Andrew Wilks
Professor Andrew Wilks is an accomplished academic scientist who worked at the LICR (Melbourne) between 1983 and 1997 and made transformative discoveries in the signal transduction field, as well as in neurogenesis and angiogenesis. He has completed a rare ‘trifecta’ – discovering and patenting a number of important drug discovery targets (e.g. JAK1 and JAK2); […]
Distinguished Professor David Adams
Distinguished Professor David Adams is internationally recognised as a leader in membrane physiology and neuroscience research, specifically the study of membrane receptor and ion channel function using molecular biological and electrophysiological recording techniques. His research over the last twenty years has characterised novel peptides isolated from the venom of cone snails as probes for ion […]
Professor Lisa Askie
Professor Lisa Askie is a neonatal nurse and midwife trained in epidemiology, who has led some of the most important practice-changing research projects in perinatology over the past 20 years. Her work has elucidated the optimal oxygen targets and cord management strategies at birth for preterm infants, the best prevention therapies for women at risk […]
Professor Andrew Forbes
Professor Andrew Forbes has an international reputation for leadership in biostatistics, stemming from his development and innovation in statistical methods to solve practical issues in health and medical research studies, as well as collaboration on major practice-changing research in substantive clinical areas. He chairs the pre-eminent multi-university national training program in biostatistics and has major […]
Professor Melanie Bahlo
Professor Melanie Bahlo is a cross-disciplinary researcher at the intersection of statistics and genetics. She has developed innovative methods and software for genetic analysis, working closely with clinicians and geneticists to gain insights into complex genetics data. Her work has helped to understand the genetic architecture of several complex diseases, in particular the causes of […]
Professor Alistair Forrest
Professor Alistair Forrest is an award-winning systems biologist whose leadership and ability to form and manage large international collaborations has led to enormous progress in our understanding of human disease. Professor Forrest applies systems-wide analyses and broad genomic surveys to deliver new, unbiased, data-driven insights into disease. His research is revealing the cellular makeup of […]
Professor Julie Bernhardt
Professor Julie Bernhardt is a Co-Head of the Stroke Theme at the Florey Institute of Neuroscience and Mental Health, a clinical scientist and highest ranked researcher in the field of stroke rehabilitation. She has established new standards and global collaborative partnerships for stroke rehabilitation trials, including completing the first landmark international trial in acute stroke […]
Professor Nicholas Buckley
Professor Nicholas Buckley’s research focusses on toxicology and adverse effects of drugs, pesticides and snakebite using a range of methods including systematic reviews, clinical trials, drug development, public health interventions, pharmaco-epidemiology and policy analysis, leading to over 300 articles in refereed journals. Many of Professor Buckley’s research findings have translated into changed practice and improved […]
Professor Lin Fritschi
Professor Lin Fritschi is a cancer epidemiologist and public health physician with specific expertise in occupational causes of cancer. Her research revolves around two themes: identifying occupational causes of cancer and improving methods for assessing occupational exposure in epidemiological studies. She has a substantial track record of publications, grants and impact on policy, has successfully […]